Buddle B M, Skinner M A, Wedlock D N, Collins D M, de Lisle G W
AgResearch, Wallaceville Animal Research Centre, P.O. Box 40063, Upper Hutt, New Zealand.
Vet Immunol Immunopathol. 2002 Sep 10;87(3-4):177-85. doi: 10.1016/s0165-2427(02)00049-1.
Advances in the understanding of protective immune responses to tuberculosis are providing opportunities for the rational development of improved vaccines for bovine tuberculosis. Protection requires activation of macrophages through stimulation of a Th 1 type immune response. Ideally, a vaccine for cattle should induce protection without causing animals to react in a tuberculin test when exposed to Mycobacterium bovis. A number of new tuberculosis vaccines including attenuated M. bovis strains, killed mycobacteria, protein and DNA vaccines have been developed and many of these are being assessed in cattle. The requirements for a tuberculosis vaccine for wildlife differ from those for cattle. The major goal of a wildlife vaccine is to prevent the transmission of M. bovis to cattle and other wildlife. Although there are a number of technical problems associated with the development of a vaccine delivery system for wildlife, attenuated M. bovis vaccines administered via oral baits or aerosol spray to possums have already been shown to reduce the severity of a subsequent M. bovis infection.
对结核病保护性免疫反应认识的进展为合理开发改进的牛结核病疫苗提供了机会。保护作用需要通过刺激Th1型免疫反应来激活巨噬细胞。理想情况下,牛用疫苗应能诱导产生保护作用,同时在动物接触牛分枝杆菌时不会使其在结核菌素试验中出现反应。已经开发出多种新型结核病疫苗,包括减毒牛分枝杆菌菌株、灭活分枝杆菌、蛋白质和DNA疫苗,其中许多正在牛身上进行评估。野生动物结核病疫苗的要求与牛用疫苗不同。野生动物疫苗的主要目标是防止牛分枝杆菌传播给牛和其他野生动物。尽管在开发野生动物疫苗递送系统方面存在一些技术问题,但通过口服诱饵或气溶胶喷雾给负鼠接种减毒牛分枝杆菌疫苗已被证明可以减轻随后牛分枝杆菌感染的严重程度。